J, B., AM, M., S, G., A, F., R, V., & C, V. (2024). Are we better together? Addressing a combined treatment of pitavastatin and temozolomide for brain cancer. European journal of pharmacology, 985, 177087. https://doi.org/10.1016/j.ejphar.2024.177087
Chicago Style (17th ed.) CitationJ, Basso, Matos AM, Ghavami S, Fortuna A, Vitorino R, and Vitorino C. "Are We Better Together? Addressing a Combined Treatment of Pitavastatin and Temozolomide for Brain Cancer." European Journal of Pharmacology 985 (2024): 177087. https://doi.org/10.1016/j.ejphar.2024.177087.
MLA (9th ed.) CitationJ, Basso, et al. "Are We Better Together? Addressing a Combined Treatment of Pitavastatin and Temozolomide for Brain Cancer." European Journal of Pharmacology, vol. 985, 2024, p. 177087, https://doi.org/10.1016/j.ejphar.2024.177087.